CM118片治疗晚期恶性肿瘤患者的安全性、耐受性、 药代动力学与初步疗效的Ⅰ期临床研究
[Translation] Phase I clinical study of safety, tolerability, pharmacokinetics and preliminary efficacy of CM118 tablets in the treatment of patients with advanced malignant tumors
主要目的: 评估CM118 片在不同剂量水平治疗晚期恶性肿瘤的安全性与耐受性。 评估CM118 的临床药代动力学特征。 次要目的: 评估CM118 片治疗晚期恶性肿瘤患者的初步疗效,探索最佳治疗剂量,为Ⅱ期临床用药提供参考。
[Translation] Main objective: To evaluate the safety and tolerability of CM118 tablets at different dose levels in the treatment of advanced malignant tumors. The clinical pharmacokinetic profile of CM118 was assessed. Secondary objective: To evaluate the preliminary efficacy of CM118 tablets in the treatment of patients with advanced malignant tumors, to explore the optimal therapeutic dose, and to provide reference for phase II clinical medication.
100 Clinical Results associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.